Moreover, a recent study with sickle cell disease patients after butyrate treatment showed increased binding of γ-globin mRNA to ribosomes in reticulocytes [7]; one could speculate that this drug might interfere with the binding of miRNAs and AGO proteins to γ-globin mRNA, leading to increased HbF expression. This evidence concerns the gene FBXW7 and sickle cell disease.